• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支架置入术后冠状动脉压力测量可预测随访期不良事件:一项多中心注册研究

Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry.

作者信息

Pijls Nico H J, Klauss Volker, Siebert Uwe, Powers Eric, Takazawa Kenji, Fearon William F, Escaned Javier, Tsurumi Yukio, Akasaka Takashi, Samady Habib, De Bruyne Bernard

机构信息

Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands.

出版信息

Circulation. 2002 Jun 25;105(25):2950-4. doi: 10.1161/01.cir.0000020547.92091.76.

DOI:10.1161/01.cir.0000020547.92091.76
PMID:12081986
Abstract

BACKGROUND

Coronary stenting is associated with a restenosis rate of 15% to 20% at 6-month follow-up, despite optimum angiographic stent implantation. In this multicenter registry, we investigated the relation between optimum physiological stent implantation as assessed by poststent fractional flow reserve (FFR) and outcome at 6 months.

METHODS AND RESULTS

In 750 patients, coronary pressure measurement at maximum hyperemia was performed after angiographically apparently satisfactory stent implantation. Poststenting FFR was calculated and related to major adverse events (including need for repeat target vessel revascularization) at 6 months. In 76 patients (10.2%), at least 1 adverse event occurred. Five patients died, 19 experienced myocardial infarction, and 52 underwent at least 1 repeat target vessel revascularization. By multivariate analysis, FFR immediately after stenting was the most significant independent variable related to all types of events. In 36% of the patients, FFR normalized (>0.95), and event rate was 4.9% in that group. In 32% of the patients, poststent FFR was between 0.90 and 0.95, and event rate was 6.2%. In 32% of patients, poststent FFR was <0.90, and event rate was 20.3%. In 6% of the patients, FFR was <0.80, and event rate was 29.5% (P<0.001).

CONCLUSIONS

FFR after stenting is a strong independent predictor of outcome at 6 months.

摘要

背景

尽管冠状动脉支架植入术在血管造影下达到了最佳效果,但在6个月的随访中,其再狭窄率仍为15%至20%。在这个多中心注册研究中,我们调查了通过支架植入后血流储备分数(FFR)评估的最佳生理性支架植入与6个月时的预后之间的关系。

方法和结果

在750例患者中,在血管造影显示支架植入明显满意后,于最大充血时进行冠状动脉压力测量。计算支架植入后的FFR,并将其与6个月时的主要不良事件(包括再次进行靶血管血运重建的需求)相关联。76例患者(10.2%)发生了至少1次不良事件。5例患者死亡,19例发生心肌梗死,52例至少接受了1次再次靶血管血运重建。通过多变量分析,支架植入后即刻的FFR是与所有类型事件相关的最显著独立变量。36%的患者FFR恢复正常(>0.95),该组的事件发生率为4.9%。32%的患者支架植入后的FFR在0.90至0.95之间,事件发生率为6.2%。32%的患者支架植入后的FFR<0.90,事件发生率为20.3%。6%的患者FFR<0.80,事件发生率为29.5%(P<0.001)。

结论

支架植入后的FFR是6个月时预后的有力独立预测指标。

相似文献

1
Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry.支架置入术后冠状动脉压力测量可预测随访期不良事件:一项多中心注册研究
Circulation. 2002 Jun 25;105(25):2950-4. doi: 10.1161/01.cir.0000020547.92091.76.
2
Fractional flow reserve for the prediction of cardiac events after coronary stent implantation: results of a multivariate analysis.冠状动脉支架植入术后预测心脏事件的血流储备分数:多变量分析结果
Heart. 2005 Feb;91(2):203-6. doi: 10.1136/hrt.2003.027797.
3
Relation of fractional flow reserve after drug-eluting stent implantation to one-year outcomes.药物洗脱支架置入术后的血流储备分数与一年结局的关系。
Am J Cardiol. 2011 Jun 15;107(12):1763-7. doi: 10.1016/j.amjcard.2011.02.329. Epub 2011 Apr 8.
4
Fractional flow reserve predicts major adverse cardiac events after coronary stent implantation.血流储备分数可预测冠状动脉支架植入术后的主要不良心脏事件。
Z Kardiol. 2002;91 Suppl 3:132-6. doi: 10.1007/s00392-002-1324-y.
5
Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI).随机比较血流储备分数指导下和血管造影指导下的真性冠状动脉分叉病变的临时支架置入术:DKCRUSH-VI 试验(双对吻挤压术与分叉病变治疗中临时支架置入术的 VI 代技术)。
JACC Cardiovasc Interv. 2015 Apr 20;8(4):536-46. doi: 10.1016/j.jcin.2014.12.221. Epub 2015 Mar 26.
6
Impact of lesion characteristics on the prediction of optimal poststent fractional flow reserve.病变特征对支架置入后最佳血流储备分数预测的影响
Am Heart J. 2016 Dec;182:119-124. doi: 10.1016/j.ahj.2016.09.015. Epub 2016 Oct 4.
7
Clinical significance of fractional flow reserve for evaluation of functional lesion severity in stent restenosis and native coronary arteries.
Chest. 2005 Sep;128(3):1645-9. doi: 10.1378/chest.128.3.1645.
8
Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study.药物洗脱支架植入后即刻测量血流储备分数对冠心病患者临床事件的截断值和长期预测:来自 DKCRUSH VII 注册研究的 1 至 3 年结果。
JACC Cardiovasc Interv. 2017 May 22;10(10):986-995. doi: 10.1016/j.jcin.2017.02.012. Epub 2017 Apr 26.
9
Clinical Relevance of Poststent Fractional Flow Reserve After Drug-Eluting Stent Implantation.药物洗脱支架植入术后支架后血流储备分数的临床相关性
J Invasive Cardiol. 2015 Aug;27(8):346-51.
10
Long-Term Clinical Outcomes of Fractional Flow Reserve-Guided Versus Routine Drug-Eluting Stent Implantation in Patients With Intermediate Coronary Stenosis: Five-Year Clinical Outcomes of DEFER-DES Trial.经皮冠状动脉介入治疗中临界病变患者应用血流储备分数指导与常规药物洗脱支架置入的长期临床结局:DEFER-DES 试验 5 年临床结局。
Circ Cardiovasc Interv. 2015 Dec;8(12):e002442. doi: 10.1161/CIRCINTERVENTIONS.115.002442.

引用本文的文献

1
Virtual Stenting Based on Fractional Flow Reserve Derived from Computed Tomography in Predicting Post-Percutaneous Coronary Intervention Functional Outcomes: A Retrospective Cohort Study.基于计算机断层扫描衍生的血流储备分数的虚拟支架置入术预测经皮冠状动脉介入术后功能结局:一项回顾性队列研究
J Cardiovasc Dev Dis. 2025 Sep 22;12(9):373. doi: 10.3390/jcdd12090373.
2
Clinical implication of post-angioplasty quantitative flow ratio in the patients with coronary artery de novo lesions underwent drug-coated balloons treatment.冠状动脉初发病变患者接受药物涂层球囊治疗后血管成形术后定量血流比的临床意义
J Geriatr Cardiol. 2025 Mar 28;22(3):332-343. doi: 10.26599/1671-5411.2025.03.006.
3
Impact of Post Percutaneous Coronary Intervention Fractional Flow Reserve on 5-Year Clinical Outcomes (The FFR SEARCH Study).
经皮冠状动脉介入治疗后血流储备分数对5年临床结局的影响(FFR研究)
Catheter Cardiovasc Interv. 2025 May;105(6):1523-1529. doi: 10.1002/ccd.31493. Epub 2025 Mar 12.
4
Differences in severity of diffuse and focal coronary stenosis between visual and quantitative assessment.视觉评估与定量评估在弥漫性和局灶性冠状动脉狭窄严重程度上的差异。
Front Cardiovasc Med. 2024 Dec 16;11:1501576. doi: 10.3389/fcvm.2024.1501576. eCollection 2024.
5
Fractional Flow Reserve Directed Percutaneous Coronary Intervention Optimization Using High-Definition Intravascular Ultrasound in Non-ST-Segment Elevation Acute Coronary Syndrome Versus Chronic Coronary Syndrome.非ST段抬高型急性冠状动脉综合征与慢性冠状动脉综合征中使用高清血管内超声优化血流储备分数指导的经皮冠状动脉介入治疗
Catheter Cardiovasc Interv. 2025 Jul;106(1):12-22. doi: 10.1002/ccd.31357. Epub 2024 Dec 25.
6
Deforming Patient-Specific Models of Vascular Anatomies to Represent Stent Implantation via Extended Position Based Dynamics.通过基于扩展位置动力学的方法对特定患者的血管解剖模型进行变形,以呈现支架植入情况。
Cardiovasc Eng Technol. 2024 Dec;15(6):760-774. doi: 10.1007/s13239-024-00752-z. Epub 2024 Oct 1.
7
Clinical Relevance of Impaired Physiological Assessment After Percutaneous Coronary Intervention: A Meta-analysis.经皮冠状动脉介入治疗后生理评估受损的临床相关性:一项荟萃分析。
J Soc Cardiovasc Angiogr Interv. 2022 Sep 8;1(6):100448. doi: 10.1016/j.jscai.2022.100448. eCollection 2022 Nov-Dec.
8
A Visualized Nomogram for Predicting Prognosis in Elderly Patients after Percutaneous Coronary Intervention.一种用于预测老年患者经皮冠状动脉介入治疗后预后的可视化列线图。
Rev Cardiovasc Med. 2024 May 6;25(5):155. doi: 10.31083/j.rcm2505155. eCollection 2024 May.
9
Angiographic Findings and Post-Percutaneous Coronary Intervention Fractional Flow Reserve.血管造影表现与经皮冠状动脉介入术后的血流储备分数。
JAMA Netw Open. 2024 Jun 3;7(6):e2418072. doi: 10.1001/jamanetworkopen.2024.18072.
10
Angiography-based Fractional Flow Reserve for the Prediction of Clinical Outcomes After Drug-coated Balloon or Plain Old Balloon Angioplasty.基于血管造影的血流储备分数用于预测药物涂层球囊或普通球囊血管成形术后的临床结局
Cardiovasc Drugs Ther. 2025 Aug;39(4):791-800. doi: 10.1007/s10557-024-07575-z. Epub 2024 May 28.